Search Within

Mark Kris

  1. "Jose Baselga"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (7)
  3. Thoracic Oncology (7)
  4. Genitourinary Oncology Service (6)
  5. Department of Pathology and Laboratory Medicine (5)
  6. Early Drug Development Service (5)

More Groups

People
  1. Jose Baselga (7)
  2. Bob Li (5)
  3. David Hyman (5)
  4. Maria Arcila (5)
  5. Alexander Drilon (4)
  6. Charles Rudin (4)

More People

Years
  1. 2018 (2)
  2. 2017 (1)
  3. 2016 (1)
  4. 2015 (1)
  5. 1993 (2)
Publications
  1. Journal of Clinical Oncology (3)
  2. Cancer Discovery (1)
  3. Cancer Research (1)
  4. Investigational New Drugs (1)
  5. Journal of Nuclear Medicine (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (2)
  3. Society of Nuclear Medicine (1)
  4. Springer (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial
    Journal Article

    Li, B. T.; Shen, R. L.; Buonocore, D.; Olah, Z. T.; Ni, A.; Ginsberg, M. S.; Ulaner, G. A.; Offin, M.; Feldman, D.; Hembrough, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies
    Journal Article

    Jordan, E. J.; Kim, H. R.; Arcila, M. E.; Barron, D.; Chakravarty, D.; Gao, J. J.; Chang, M. T.; Ni, A.; Kundra, R.; Jonsson, P.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection
    Meeting Abstract

    Jordan, E.; Barron, D.; Schultz, N.; Chakravarty, D.; Kris, M. G.; Rudin, C. M.; Li, B. T.; Yu, H. A.; Drilon, A. E.; Rusch, V. W.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for HER2 amplified or HER2 overexpressed cancers: A phase II "basket" trial
    Meeting Abstract

    Li, B. T.; Zauderer, M.; Chaft, J.; Drilon, A.; Eng, J.; Sima, C.; Makker, V.; Iyer, G.; Janjigian, Y.; Hyman, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Comparison of phase I trials of anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (MABS) 528 and 225 labeled with I-131 and In-111
    Meeting Abstract

    Scott, A. M.; Baselga, J.; Divgi, C. R.; Pfister, D.; Kris, M.; Zhang, J. J.; Daghighian, F.; Carmichael, N.; Oettgen, H. F.; Larson, S. M.; more...
    Journal of Nuclear Medicine (1993)

    Fulltext@MSK | Save
  • Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer
    Journal Article

    Baselga, J.; Kris, M. G.; Scher, H. I.; Phillips, M.; Heelan, R. T.
    Investigational New Drugs (1993)

    Fulltext@MSK | Save